XML 32 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Derivative Financial Instruments
9 Months Ended
Sep. 30, 2021
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments

13. Derivative Financial Instruments

The Company is exposed to market risks, including changes in interest rates. To manage the risk related to these exposures, the Company has entered into various derivative instruments that reduce these risks by creating offsetting exposures.

Interest Rate Swaps

The Company has utilized swap agreements that will fix the floating interest rates associated with its Term Loan as shown in the following table:

Designation Date

 

Effective Date

 

Initial Notional Amount

 

 

Notional Amount Outstanding as of September 30, 2021

 

 

Fixed Rate

 

Expiration Date

July 2021

 

August 2020

 

 

 

557,500,000

 

 

 

 

557,500,000

 

 

 

2.5070

 

%

 

May 2022

July 2021

 

August 2020

 

 

 

89,863,420

 

 

 

 

98,078,920

 

 

 

3.0854

 

%

 

February 2023

July 2021

 

August 2020

 

 

 

181,205,050

 

 

 

 

168,155,300

 

 

 

0.7775

 

%

 

May 2024

July 2021

 

August 2020

 

 

 

388,877,200

 

 

 

 

373,963,200

 

 

 

0.7430

 

%

 

May 2024

July 2021

 

May 2022

 

 

 

220,130,318

 

 

 

n/a

 

 

 

0.5170

 

%

 

May 2024

July 2021

 

May 2022

 

 

 

306,004,562

 

 

 

n/a

 

 

 

0.5127

 

%

 

May 2024

 

Concurrent with execution of the Business Combination and the $556 million pay down of the Term Loan, three hedges were terminated, and two previously unfloored hedges were amended to incorporate an interest rate floor of 50 bps. All interest rate swaps were redesignated as cash flow hedges in accordance with ASC 805.

Our swap agreements amortize or accrete based on achieving targeted hedge ratios. All interest rate swaps have been designated as cash flow hedges. As a result of the amendment, the fair value of the instruments at the time of re-designation are being amortized into interest expense over the remaining life of the instruments.

Financial Instrument Presentation

The fair values and location of outstanding derivative instruments recorded in the Condensed Consolidated Balance Sheets are as follows (in millions):

 

 

Successor

 

 

 

Predecessor

 

 

 

September 30,

 

 

 

December 31,

 

 

 

2021

 

 

 

2020

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Other assets

 

$

 

5

 

 

 

$

 

 

Total

 

$

 

5

 

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

Other current liabilities

 

$

 

12

 

 

 

$

 

28

 

Other liabilities

 

 

 

1

 

 

 

 

 

19

 

Total

 

$

 

13

 

 

 

$

 

47

 

 

The Company estimates that approximately $2 million of derivative losses included in Accumulated other comprehensive loss as of September 30, 2021 will be reclassified into earnings over the next twelve months.